Who runs clinical trials?

Universities, hospitals and nonprofits lead about 320,000 of the 461,000 clinical trials registered on ClinicalTrials.gov as of September 2026, about 7 in 10. Drug, device and other companies lead about 113,000, or about 1 in 4; the U.S. National Institutes of Health leads about 7,900. The lead sponsor is the organization responsible for the trial; others may help pay for it.

The interactive chart needs JavaScript. The numbers are in the table below.

The value axis starts at zero. Hover, tap or use the arrow keys to read exact values.

Save a simple drawing of this chart for slides, essays or posts, with its question, source, date and a link back to this page. Please keep the credit.

Download image

Key facts

Measure: Clinical trials (all years). Written from the data below.

  • Universities, hospitals and nonprofits has the highest figure, 321,826, followed by Companies (113,823) and Other governments (11,125).
  • Individuals has the lowest figure, 459, followed by Research networks (3,672) and Other U.S. federal agencies (4,314).
  • The highest is 701 times the lowest.

Source and date

Data as of
Published

Citation

Chartly. “Who runs clinical trials?” Chart. Data: ClinicalTrials.gov (U.S. National Library of Medicine), counted with its API v2, https://clinicaltrials.gov/data-api/api (data as of October 14, 2026). https://chart.ly/charts/clinical-trials-by-sponsor (accessed October 15, 2026).

Free for your article, blog or class page: paste this code where the chart should go. It shows the interactive chart with its source and a small “Chart by Chartly” credit, and stays up to date when the data changes.

The file has the numbers in this table, with the source, license and date. Please credit the source and Chartly.

Lead sponsor Clinical trials (all years)
Universities, hospitals and nonprofits 321,826
Companies 113,823
Other governments 11,125
U.S. National Institutes of Health 7,881
Other U.S. federal agencies 4,314
Research networks 3,672
Individuals 459

Get new charts weekly

One email a week with the newest charts and their key numbers. No account needed.